Edwards Lifesciences (EW) Income from Non-Controlling Interests (2023 - 2026)
Edwards Lifesciences (EW) posted quarterly Income from Non-Controlling Interests of -$0.0 for Q4 2025, up 100.0% year-over-year from -$0.0 in Q4 2024, and up 100.0% quarter-over-quarter from -$800000.0 in Q3 2025.
Edwards Lifesciences (EW) Income from Non-Controlling Interests (2023 - 2026) Analysis & Trends
Edwards Lifesciences' Income from Non-Controlling Interests history runs 3 years deep, the most recent figure standing at -$0.0 for Q4 2025.
- In Q4 2025, Income from Non-Controlling Interests rose 100.0% year-over-year to -$0.0; the TTM figure through Mar 2026 stood at -$2.5 million (up 55.36% YoY), while the FY2025 annual figure was -$4.1 million, up 16.33% from the prior year.
- Income from Non-Controlling Interests for Q4 2025 stood at -$0.0, up from -$800000.0 in the prior quarter.
- The five-year high for Income from Non-Controlling Interests was -$0.0 in Q4 2025, with the low at -$1.7 million in Q2 2025.
- The 3-year median for Income from Non-Controlling Interests is -$1.3 million (2024), against an average of -$1.1 million.
- The sharpest annual moves came in 2024 and 2025: Income from Non-Controlling Interests tumbled 550.0% in 2024, then soared 100.0% in 2025.
- Edwards Lifesciences' Income from Non-Controlling Interests stood at -$200000.0 in 2023, then sank by 550.0% to -$1.3 million in 2024, then jumped by 100.0% to -$0.0 in 2025.
- Business Quant data shows EW's Income from Non-Controlling Interests at -$0.0 in Q4 2025, -$800000.0 in Q3 2025, and -$1.7 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.07 Bn | 193.46 Bn | 7.27 Bn | - |
| 2 | Stryker | 127.90 Bn | 124.43 Bn | 4.50 Bn | - |
| 3 | Medtronic | 118.84 Bn | 109.62 Bn | 6.41 Bn | 16.00 Mn |
| 4 | Boston Scientific | 73.33 Bn | 72.79 Bn | 3.85 Bn | -2.00 Mn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | -500,000.00 |
| 6 | Dexcom | 34.46 Bn | 32.51 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.91 Bn | 31.81 Bn | 2.18 Bn | 13.00 Mn |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | 2.32 Mn |
| 9 | Steris | 23.12 Bn | 22.64 Bn | 684.20 Mn | 900,000.00 |
| 10 | Zimmer Biomet Holdings | 19.26 Bn | 18.85 Bn | 1.54 Bn | 1.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -500,000.00 |
| Dec 31, 2025 | 0.00 |
| Sep 30, 2025 | -800,000.00 |
| Jun 30, 2025 | -1.70 Mn |
| Mar 31, 2025 | -1.60 Mn |
| Dec 31, 2024 | -1.30 Mn |
| Sep 30, 2024 | -1.40 Mn |
| Jun 30, 2024 | -1.30 Mn |
| Mar 31, 2024 | -900,000.00 |
| Dec 31, 2023 | -200,000.00 |
| Sep 30, 2023 | -1.20 Mn |
| Jun 30, 2023 | -1.60 Mn |